Distribution of α1-adrenoceptor subtype mRNA and identification of subtype responsible for renovascular contraction in human renal artery

Life Sciences

Volumn 66, Issue 10, 2000, Pages 915-926

  Moriyama, Nobuo ^a   Kurooka, Yuji ^a   Nasu, Kimio ^a,b   Akiyama, Katsuyoshi ^a,c   Takeuchi, Takumi ^a   Nishimatsu, Hiroaki ^a   Murata, Satoshi ^a,c   Murayama, Takeo ^a   Tsujimoto, Gozoh ^a,d   Kawabe, Kazuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NIPPON SHINYAKU CO LTD   (Japan)

^c KISSEI PHARMACEUTICAL CO LTD   (Japan)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

1 adrenoceptor subtype mRNA; Human renal artery; In situ hybridization; RNase protection assay

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLOROETHYLCLONIDINE; CORTICOSTERONE; DESIPRAMINE; MESSENGER RNA; NORADRENALIN; PRAZOSIN; PROPRANOLOL; RECEPTOR SUBTYPE; SILODOSIN; TAMSULOSIN; YOHIMBINE; ALPHA 1 ADRENERGIC RECEPTOR; RNA;

ADULT; AGED; ARTERY CONSTRICTION; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KIDNEY ARTERY; PROSTATE; PROTEIN LOCALIZATION; RIBONUCLEASE PROTECTION ASSAY; RNA PROBE; TUNICA MEDIA; CLASSIFICATION; DRUG EFFECT; GENETICS; MIDDLE AGED; MUSCLE CONTRACTION; PHYSIOLOGY; RENAL ARTERY;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; MUSCLE CONTRACTION; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-1; RENAL ARTERY; RNA; RNA PROBES;

EID: 0034723076     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00675-X     Document Type: Article

References (35)

1. 1. J.F. Bruno, J. Whittaker, J. Song and M. Berelowitz, Biochem. Biophys. Res. Commun. 179 1485-1490 (1991).
2. 2. A. Hirasawa, K. Horie, T. Tanaka, K. Takagaki, M. Murai, J. Yano and G. Tsujimoto, Biochem. Biophys. Res. Commun. 195 902-909 (1993).
3. 3. D.A. Schwinn, G.I. Johnston, S.O. Page, M.J. Mosley, K.H. Wilson, N.P. Worman, S. Campbell, M.D. Fidock, L.M. Furness, D.J. Parry-Smith, B. Peter and D.S. Bailey, J Pharmacol Exp Ther 272 134-142 (1995).
4. 4. J.P. Hieble, D.B. Bylund, D.E. Clarke, D.C. Eikenburg, S.Z. Langer, R.J. Lefkowitz, K.P. Minneman and R.R.J. Ruffolo, Pharmacol. Rev. 47 267-270 (1995.).
5. 5. R. Donnelly, P.A. Meredith and H.L. Elliott, Clin. Pharmacokinet. 17 264-274 (1989).
6. 6. L. Barajas and P. Wang, Anat. Res. 195 525-534 (1989).
7. 7. C. Han, J. Li and K.P. Minneman, Eur J Pharmacol 190 97-104 (1990).
8. 8. D.R. Blue, Jr., R.L. Vimont and D.E. Clarke, Br. J. Pharmacol. 107 414-417 (1992).
9. 9. D.W. Wolff, F.A. Gesek and J.W. Atandhoy, J. Pharmasol. Exp. Ther. 241 472-476. (1987).
10. 10. A.M. Elhawary, W.A. Pettinger and D.W. Wolff, J Pharmacol Exp Ther 260 709-13 (1992).
11. 11. Y. Kohno, H. Saito, M. Takita, S. Kigoshi and I. Muramatsu, Br J Pharmacol 112 1167-73 (1994).
12. 12. T. Fujiwara and S. Chiba, Jpn J Pharmacol 61 171-6 (1993).
13. 13. M.P. Owen, J Pharmacol Exp Ther 265 807-12 (1993).
14. 14. J.A. Studer and R.W. Piepho, J. Clin. Pharmacol. 33 2-13 (1993).
15. 15. D.T. Price, D.A. Schwinn, J.W. Lomasney, L.F. Allen, M.G. Caron and P.J. Lefkowitz, J Urol 150 546-551 (1993).
16. 16. D.H. Weinberg, P. Trivedi, C.P. Tan, S. Mitra, A. Perkins-Barrow, D. Borkowski, C.D. Strader and M. Bayne, Biochem. Biophys. Res. Commun. 201 1296-1304 (1994).
17. 17. D.T. Price, R.J. Lefkowitz, M.G. Caron, D. Berkowitz and D.A. Schwinn, Mol Pharmacol 45 171-175 (1994).
18. 18. N. Moriyama, S. Kuriomoto, S. Horie, K. Nasu, T. Tanaka, J. Yano, H. Hirano, G. Tsujimoto and K. Kawabe, Histochem. J. 28 283-288 (1996).
19. 19. K. Nasu, N. Moriyama, K. Kawabe, G. Tsujimoto, M. Murai, T. Tanaka and J. Yano, Br. J. Pharmacol. 119 797-803 (1996).
20. 20. I. Muramatsu, T. Ohmura, S. Hashimoto and M. Oshita, Pharmacol. Comm 6 23-28 (1995).
21. 21. R. Testa, L. Guarneri, C. Taddei, E. Poggesi, P. Angelico, A. Sartani, A. Leonardi, O.N. Gofrit, S. Meretyk and M. Caine, J. Pharmacol. Exp. Ther 277 1237-1246 (1996).
22. 22. P. Chomczymski and N. Sacchi, Anal. Biochem. 162 156-159 (1987).
23. 23. O. Arunlakshana and H.O. Schild, Br. J. Pharmacol. 14 48-52 (1959).
24. 24. A. Hatano, H. Takahashi, M. Tamaki, T. Komeyama, T. Koizumi and M. Takeda, Br J Pharmacol 113 723-8 (1994).
25. 25. N. Moriyama, K. Nasu, T. Takeuchi, K. Akiyama, S. Murata, H. Nishimatsu, J. Yano, G. Tujimoto and K. Kawabe, Br. J. Pharmacol. 122 1009-1014 (1997).
26. 26. M.T. Piascik, M.S. Smith, E.E. Soltis and D.M. Perez, Mol Pharmacol 46 30-40 (1994).
27. 27. S.M. Abdul and E.J. Johns, J. Cardiovasc. Pharmacol. 24 420-428 (1994).
28. 28. J.R. Docherty and M. O'Rourke, Gen. Pharmacol. 28 197-201 (1997)
29. 29. R.M. Graham, D.M. Perez, J. Hwa and M.T. Piascik, Circ. Res. 78 737-749 (1996)
30. 30. I. Muramatsu, T. Ohmura, S. Kigoshi, S. Hashimoto and M. Oshita, Br. J. Pharmacol. 99 197-201 (1990)
31. 31 A.P.D.W. Ford, D.V. Daniels, D.J. Chang, J.R. Gever, J.R. Jasper, J.D. Lesnick and D.E. Clarke, Br. J. Pharmacol. 121 1127-1135 (1997)
32. 32. R. Yamagishi, K. Akiyama, S. Nakamura, M. Hora, N. Masuda, A. Matsuzawa, S. Murata, A. Ujiie, Y. Kurashina, K. Iizuka and M. Kitazawa, Eur. J. Pharmacol. 315 73-79 (1996).
33. 33. N. Moriyama, K. Akiyama, S. Murata, J. Taniguchi, N. Ishida, S. Yamazaki and K. Kawabe, Eur. J. Pharmacol. 331 39-42. (1997).
34. 34. K. Shibata, R. Foglar, K. Horie, K. Obika, A. Sakamoto, S. Ogawa and G. Tsujimoto, Mol Pharmacol 48 250-258 (1995).
35. 35. A.J. Noble, R. Chess-Williams, C. Couldwell, K. Furukawa, T. Uchiyama, C. Korstanje and C.R. Chapple, Br. J. Pharmacol. 120 231-238 (1997).